Supply cost and outcome comparison of nBCA, Onyx, and coils for middle meningeal artery embolizations: a single-center retrospective analysis.

IF 4.3 1区 医学 Q1 NEUROIMAGING
Kiernan Joseph Gunn, Eric Sleasman, Sajal Medha K Akkipeddi, Prasanth Romiyo, Eric Davis, Pablo Valdes Barrera, Santiago Mendoza-Ayus, Vidhya Dhar, Derrek Schartz, Vincent N Nguyen, Tarun Bhalla, Thomas Mattingly, Matthew T Bender
{"title":"Supply cost and outcome comparison of nBCA, Onyx, and coils for middle meningeal artery embolizations: a single-center retrospective analysis.","authors":"Kiernan Joseph Gunn, Eric Sleasman, Sajal Medha K Akkipeddi, Prasanth Romiyo, Eric Davis, Pablo Valdes Barrera, Santiago Mendoza-Ayus, Vidhya Dhar, Derrek Schartz, Vincent N Nguyen, Tarun Bhalla, Thomas Mattingly, Matthew T Bender","doi":"10.1136/jnis-2025-024003","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Middle meningeal artery (MMA) embolization is increasingly utilized in the treatment of chronic subdural hematoma (cSDH); however, supply cost variation between embolization agents remains unclear. We hypothesized that nBCA might be associated with lower costs, given the ability to use a single vial and treat multiple pedicles.</p><p><strong>Objective: </strong>To compare the supply costs of MMA embolizations using ethylene vinyl-alcohol copolymer-based Onyx (Onyx), n-butyl cyanoacrylate-based TRUFILL (nBCA), and/or coils.</p><p><strong>Methods: </strong>This retrospective study analyzed 100 consecutive MMA embolizations performed at a single institution before March 2025. The supplies (including catheters and embolic agents) used in each embolization, along with procedure time, laterality, and number of pedicles embolized, were documented. Radiographic and clinical patient outcomes were evaluated.</p><p><strong>Results: </strong>Of the 100 procedures: 63 used nBCA, 26 Onyx, 2 coils, 2 nBCA and coils, and 7 Onyx and coils. Supply costs ranged from approximately $5000 to $18 000. Onyx was significantly less expensive than nBCA in supply cost per patient ($7910 vs $10 241; P<0.0001), cost per side ($6467 vs $7857; P=0.010), and cost per pedicle ($4375 vs $5369; P=0.012). Mean cost per patient was highest for nBCA and coils ($13 541 ± $1331), Onyx and coils ($12 364 ± $3259), and coils alone ($11 058 ± $1144). There were no significant differences in short-term complications (stroke, seizure, cranial nerve palsy, retreatment, hospital readmissions; P>0.05), functional outcomes (modified Rankin Scale; P=0.813), or complete cSDH resolution (P=0.149) between embolic techniques.</p><p><strong>Conclusions: </strong>There is significant variation in supply cost associated with different MMA embolization techniques. In our institutional experience, Onyx was associated with the lowest supply cost per patient, hemisphere, and pedicle. Complication rates and functional status did not significantly differ across techniques.</p>","PeriodicalId":16411,"journal":{"name":"Journal of NeuroInterventional Surgery","volume":" ","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of NeuroInterventional Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/jnis-2025-024003","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROIMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Middle meningeal artery (MMA) embolization is increasingly utilized in the treatment of chronic subdural hematoma (cSDH); however, supply cost variation between embolization agents remains unclear. We hypothesized that nBCA might be associated with lower costs, given the ability to use a single vial and treat multiple pedicles.

Objective: To compare the supply costs of MMA embolizations using ethylene vinyl-alcohol copolymer-based Onyx (Onyx), n-butyl cyanoacrylate-based TRUFILL (nBCA), and/or coils.

Methods: This retrospective study analyzed 100 consecutive MMA embolizations performed at a single institution before March 2025. The supplies (including catheters and embolic agents) used in each embolization, along with procedure time, laterality, and number of pedicles embolized, were documented. Radiographic and clinical patient outcomes were evaluated.

Results: Of the 100 procedures: 63 used nBCA, 26 Onyx, 2 coils, 2 nBCA and coils, and 7 Onyx and coils. Supply costs ranged from approximately $5000 to $18 000. Onyx was significantly less expensive than nBCA in supply cost per patient ($7910 vs $10 241; P<0.0001), cost per side ($6467 vs $7857; P=0.010), and cost per pedicle ($4375 vs $5369; P=0.012). Mean cost per patient was highest for nBCA and coils ($13 541 ± $1331), Onyx and coils ($12 364 ± $3259), and coils alone ($11 058 ± $1144). There were no significant differences in short-term complications (stroke, seizure, cranial nerve palsy, retreatment, hospital readmissions; P>0.05), functional outcomes (modified Rankin Scale; P=0.813), or complete cSDH resolution (P=0.149) between embolic techniques.

Conclusions: There is significant variation in supply cost associated with different MMA embolization techniques. In our institutional experience, Onyx was associated with the lowest supply cost per patient, hemisphere, and pedicle. Complication rates and functional status did not significantly differ across techniques.

nBCA、Onyx和线圈用于脑膜中动脉栓塞的供应成本和结果比较:单中心回顾性分析。
背景:脑膜中动脉(MMA)栓塞越来越多地用于治疗慢性硬膜下血肿(cSDH);然而,栓塞剂之间的供应成本差异尚不清楚。我们假设nBCA可能与较低的成本有关,因为它能够使用一个小瓶治疗多个蒂。目的:比较使用乙烯乙烯醇共聚物基玛瑙(Onyx)、氰基丙烯酸正丁酯基TRUFILL (nBCA)和/或线圈进行MMA栓塞的供应成本。方法:本回顾性研究分析了2025年3月前在一家机构连续进行的100例MMA栓塞。记录了每次栓塞中使用的导管和栓塞剂,以及手术时间、侧边性和栓塞蒂的数量。评估患者的影像学和临床结果。结果:100例手术中:nBCA 63例,Onyx 26例,线圈2例,nBCA +线圈2例,Onyx +线圈7例。供应费用约为5000美元至18 000美元。在栓塞技术之间,Onyx在每位患者的供应成本(7910美元vs 10241美元;P0.05)、功能结局(改良Rankin量表;P=0.813)或完全cSDH解决(P=0.149)方面明显低于nBCA。结论:不同的MMA栓塞技术在供应成本上存在显著差异。在我们的机构经验中,玛瑙与每位患者、半球和椎弓根的最低供应成本有关。不同手术方法的并发症发生率和功能状态无显著差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.50
自引率
14.60%
发文量
291
审稿时长
4-8 weeks
期刊介绍: The Journal of NeuroInterventional Surgery (JNIS) is a leading peer review journal for scientific research and literature pertaining to the field of neurointerventional surgery. The journal launch follows growing professional interest in neurointerventional techniques for the treatment of a range of neurological and vascular problems including stroke, aneurysms, brain tumors, and spinal compression.The journal is owned by SNIS and is also the official journal of the Interventional Chapter of the Australian and New Zealand Society of Neuroradiology (ANZSNR), the Canadian Interventional Neuro Group, the Hong Kong Neurological Society (HKNS) and the Neuroradiological Society of Taiwan.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信